Attached files

file filename
10-K - FORM 10-K - INSPIRE PHARMACEUTICALS INCd10k.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLC - INSPIRE PHARMACEUTICALS INCdex231.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - INSPIRE PHARMACEUTICALS INCdex311.htm
EX-10.57 - AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY, DATED NOVEMBER 17, 2010 - INSPIRE PHARMACEUTICALS INCdex1057.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - INSPIRE PHARMACEUTICALS INCdex322.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - INSPIRE PHARMACEUTICALS INCdex312.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of Inspire Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, Adrian Adams, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 25, 2011

 

/s/    ADRIAN ADAMS        

Adrian Adams

President & Chief Executive Officer

(principal executive officer)